Department of General Surgery, Gansu Provincial Hospital, 204 Donggang West Road, Lanzhou, 730000, People's Republic of China.
Department of Clinical Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, People's Republic of China.
Surg Endosc. 2018 Nov;32(11):4377-4392. doi: 10.1007/s00464-018-6295-9. Epub 2018 Jun 28.
Robotic surgery, an emerging technology, has some potential advantages in many complicated endoscopic procedures compared with laparoscopic surgery. But robot-assisted cholecystectomy (RAC) is still a controversial issue on its comparative merit compared with conventional laparoscopic cholecystectomy (LC). The aim of this study was to evaluate the safety and efficacy of RAC compared with LC for benign gallbladder disease.
A systematic literature search was conducted using the PubMed, EMBASE, and Cochrane Library databases (from their inception to December 2017) to obtain comparative studies assessing the safety and efficacy between RAC and LC. The quality of the literature was assessed, and the data analyzed using R software, random effects models were applied.
Twenty-six studies, including 5 RCTs and 21 NRCSs (3 prospective plus 18 retrospective), were included. A total of 4004 patients were included, of which 1833 patients (46%) underwent RAC and 2171 patients (54%) underwent LC. No significant differences were found in intraoperative complications, postoperative complications, readmission rate, hospital stay, estimated blood loss, and conversion rate between RAC and LC groups. However, RAC was related to longer operative time compared with LC (MD = 12.04 min, 95% CI 7.26-16.82) in RCT group, which was consistent with NRCS group; RAC also had a higher rate of incisional hernia in NRCS group (RR = 3.06, 95% CI 1.42-6.57), and one RCT reported that RAC was similar to LC (RR = 7.00, 95% CI 0.38-129.84).
The RAC was not found to be more effective or safer than LC for benign gallbladder diseases, which indicated that RAC is a developing procedure instead of replacing LC at once. Given the higher costs, the current evidence is in favor of LC in cholecystectomy.
与腹腔镜手术相比,机器人手术作为一种新兴技术,在许多复杂的内镜手术中具有一定的潜在优势。但是,机器人辅助胆囊切除术(RAC)与传统腹腔镜胆囊切除术(LC)相比,其优越性仍存在争议。本研究旨在评估 RAC 治疗良性胆囊疾病的安全性和疗效。
通过PubMed、EMBASE 和 Cochrane Library 数据库(从其成立到 2017 年 12 月)进行系统文献检索,获取评估 RAC 与 LC 安全性和疗效的比较研究。评估文献质量,并使用 R 软件进行数据分析,采用随机效应模型。
共纳入 26 项研究,包括 5 项 RCT 和 21 项 NRCS(前瞻性 3 项,回顾性 18 项),共纳入 4004 例患者,其中 1833 例(46%)接受 RAC,2171 例(54%)接受 LC。RAC 组与 LC 组术中并发症、术后并发症、再入院率、住院时间、估计出血量和中转开腹率无显著差异。然而,RAC 组与 LC 组相比,手术时间较长(RCT 组 MD=12.04 分钟,95%CI 7.26-16.82;NRCS 组一致);NRCS 组切口疝发生率较高(RR=3.06,95%CI 1.42-6.57),一项 RCT 报道 RAC 与 LC 相似(RR=7.00,95%CI 0.38-129.84)。
对于良性胆囊疾病,RAC 并不比 LC 更有效或更安全,这表明 RAC 是一种发展中的手术,而不是立即取代 LC。鉴于较高的成本,目前的证据倾向于在胆囊切除术中使用 LC。